Get the Stockscreener App
7.23
1.83%
0.13
After Hours:
7.22
-0.01
-0.14%
Curanex Pharmaceuticals Inc stock is traded at $7.23, with a volume of 1.02M.
It is up +1.83% in the last 24 hours and up +0.00% over the past month.
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.
See More
Previous Close:
$7.10
Open:
$7.15
24h Volume:
1.02M
Relative Volume:
3.06
Market Cap:
$200.63M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+29.11%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$6.72
$7.48
1-Week Range:
$5.29
$7.48
52-Week Range:
$4.68
$7.48
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
Name
Curanex Pharmaceuticals Inc
Sector
Industry
Phone
-
Address
-
Compare CURX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CURX
Curanex Pharmaceuticals Inc
|
7.23 | 197.03M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Curanex Pharmaceuticals Inc Stock (CURX) Latest News
Chinese Stocks To Watch Today – September 2nd - Defense World
Chinese Stocks To Watch Today – August 31st - Defense World
Chinese Stocks To Watch TodayAugust 31st - MarketBeat
Curanex Pharmaceuticals announces pricing of its initial public offering - MSN
Promising Chinese Stocks To ConsiderAugust 30th - MarketBeat
Chinese Stocks To Research – August 29th - Defense World
Wall Street Zen Upgrades Curanex Pharmaceuticals (NASDAQ:CURX) to “Hold” - Defense World
Curanex Pharmaceuticals (NASDAQ:CURX) Raised to “Hold” at Wall Street Zen - Defense World
IPO NewsUS IPO Weekly Recap: Quiet week as IPO market gears up for a busy fall - renaissancecapital.com
Curanex Pharmaceuticals closes $15 million IPO on NASDAQ - Investing.com
Curanex Pharmaceuticals Inc. (CURX) Soars 10.52% on Successful IPO - AInvest
Curanex Pharmaceuticals shares rise 7.30% premarket after closing its initial public offering of 3,750,000 shares at $4.00 per share. - AInvest
Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering - GlobeNewswire
Curanex Pharmaceuticals' IPO: A Strategic Bet on Botanical Innovation in a Resilient Biotech Sector - AInvest
Curanex Pharmaceuticals closes $15 million IPO on NASDAQ By Investing.com - Investing.com Canada
Curanex Pharmaceuticals Inc. announces closing of its initial public offering - MarketScreener
Curanex Pharmaceuticals Completes Initial Public Offering for $15 Million - AInvest
$15 Million IPO: Inflammatory Disease Biotech Curanex Launches on Nasdaq with Botanical Drug Focus - Stock Titan
Curanex Pharmaceuticals Inc(NasdaqCM: CURX) added to NASDAQ Composite Index - MarketScreener
IPO Preview | Curanex Will be Listed on 8/26/2025 - AInvest
Curanex Pharmaceuticals prices IPO at $4 per share - Investing.com
Curanex Pharmaceuticals prices IPO at $4 per share, raises $15 million By Investing.com - Investing.com South Africa
Curanex Pharmaceuticals' Nasdaq Debut: A Cautious Bet on Botanical Innovation - AInvest
Curanex Pharmaceuticals Shares Fall in Nasdaq Debut - MarketScreener
CURX IPO NewsPreclinical biotech Curanex Pharmaceuticals prices IPO at $4, the low end of the range - renaissancecapital.com
Curanex Pharmaceuticals prices IPO at $4 per share, raises $15 million - Investing.com
Curanex Pharmaceuticals prices IPO at $4 per share By Investing.com - Investing.com UK
Curanex pharmaceuticals announces pricing of its initial public offering - MarketScreener
Curanex Pharmaceuticals announces pricing of IPO - AInvest
$15 Million IPO: Botanical Drug Developer Curanex Lists on Nasdaq to Advance Ulcerative Colitis Treatment - Stock Titan
Curanex Pharmaceuticals Plans $10 million IPO for August 26th (CURX) - Defense World
Curanex Pharmaceuticals Files for 3.75M Share IPO at $4-$6/sh - Investing.com Canada
Curanex, botanical drug developer, files for $10M IPO - MSN
Curanex Pharmaceuticals Inc Stock (CURX) Financials Data
There is no financial data for Curanex Pharmaceuticals Inc (CURX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):